According to FutureWise analysis the market for Medical Device Validation and Verification in 2026 is US$ 1.02 billion, and is expected to reach US$ 2.17 billion by 2036 at a CAGR of 7.84%. The growth is driven by stricter global regulations, increased complexity of medical devices, and the rapid adoption of software-driven technologies. Manufacturers are heavily investing in validation and verification processes to ensure patient safety, regulatory compliance, and quicker time-to-market.
Medical Device Validation and Verification (V&V) are critical processes that play a vital role in ensuring the safety, performance, and regulatory compliance of medical devices throughout their lifecycle. With the advancement of medical technologies, particularly those that rely on software, the importance of comprehensive verification and validation (V&V) processes is increasingly significant for manufacturers, regulators, and healthcare providers. This heightened focus ensures that these technologies meet safety and efficacy standards, ultimately benefiting patient care. Specifically, verification checks that a device is manufactured according to design specifications, while validation confirms that it performs its intended clinical function safely and effectively for users.
At the heart of medical device V&V is the commitment to upholding global regulatory standards and quality management systems, such as ISO 13485, ISO 14971, and IEC 62304, alongside the requirements set by regulatory bodies like the U.S. FDA and the European Medicines Agency. V&V activities span several phases, including design controls, software testing, risk management, usability engineering, manufacturing processes, and post-market surveillance. Together, these initiatives help catch potential failures early on, reduce the risk of product recalls, and maintain consistent product quality.
The rise of digital technologies—like embedded software, artificial intelligence, connectivity, and cloud-based data systems—has added a layer of complexity to medical devices, expanding the V&V scope. This evolution now incorporates essential aspects such as cybersecurity validation, software lifecycle management, and system-level performance assessments. As a result, V&V has transformed into a strategic function that extends beyond merely checking off regulatory boxes.
Additionally, the increasing global demand for faster product development cycles has driven manufacturers to adopt innovations such as automated testing, model-based validation, and continuous verification. These strategies help strike a balance between ensuring regulatory compliance and speeding up innovation and time to market. In the end, medical device validation and verification are foundational to patient safety, regulatory approval, and sustained market success, underscoring their critical importance in today’s tightly regulated and rapidly changing medical technology landscape.
FutureWise Market Research has published a report that provides an insightful analysis of Medical Device Validation and Verification Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=9565&type=requestsample
Medical Device Validation and Verification Market Segmentation:
By Therapeutic Area
• Cardiovascular
• Dermatology
• Orthopedics
• Nephrology
• Respiratory
• Neurology
• Oncology
• ENT

By Application
• Diagnostics
• Therapeutic
• Implants
o Active Implantable Medical Device
o Medical Implants

By Technology
• Mechanical testing
• Biological
• EMC/ECI
• Electrical safety testing

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Medical Device Validation and Verification Market:
• SGS SA
• QuEST Global Services Pte. Ltd
• Element Materials Technology
• TÜV SÜD AG
• North American Science Associates, Inc
• Eurofins Scientific SE
• Charles River
• Sterling Medical Devices
• Pacific Biolabs
• Toxikon Corporation
• Steris Laboratories

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=9565&license=multi


**Objectives of this Study: **
1. To provide a comprehensive analysis of the Medical Device Validation and Verification Market By Therapeutic Area, By Application, By Technology and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: [email protected]

FutureWise Research
Contact Person: Vinay Thaploo.
Email: [email protected]
Contact Number: Asia: +91 8605575209 | UK: +44 0113 519 7222
Website: www.futurewiseresearch.com